If monthly manipulation is to keep on occuring, is it in the best interests of shareholders to continue with this funding arrangement?
We are not bound to them in any way, and can seek finance elsewhere if Im not mistaken? Given that the Dendreon decision has derisked Prima to a certain extent, I think that in the interests of shareholders and the Company, alternative funding should be strongly sought!
Maybe that is what Martin Rogers is doing at the Bio Conference this week? I sure hope so.
If it werent for this blatant manipulation(is it even legal), IMO the SP would be a LOT higher!
What are your thoughts?
is springtree the best option
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 33.0¢ | $1.220M | 3.642M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 57289 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 52306 | 3 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |